25 research outputs found
Recommendations for Nanomedicine Human Subjects Research Oversight: An Evolutionary Approach for an Emerging Field
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/96363/1/j.1748-720X.2012.00703.x.pd
Mapping Interactions Between Micropatterned Hydrophobic and Hydrophilic Surfaces by Atomic Force Microscopy
115 p.Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 1998.Hydrophobic and hydrophilic interactions are not additive and the net interactions between heterogeneous surfaces depend on the relative size of hydrophobic and hydrophilic sites on the surface. Independent on whether the hydrophobic sphere is positioned on top of a hydrophobic or hydrophilic area, repulsions are measured, with the same strength and decay length of the electrostatic interaction. Jump into contact distances and adhesion data, between a 20 m hydrophobic sphere and a heterogeneous surface that has equal hydrophobic and hydrophilic areas will average, whereas in all other cases the hydrophobic sphere will clearly differentiate between the different areas, accurately mapping high and low adhesion areas on the surface.U of I OnlyRestricted to the U of I community idenfinitely during batch ingest of legacy ETD
Mapping Interactions Between Micropatterned Hydrophobic and Hydrophilic Surfaces by Atomic Force Microscopy
115 p.Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 1998.Hydrophobic and hydrophilic interactions are not additive and the net interactions between heterogeneous surfaces depend on the relative size of hydrophobic and hydrophilic sites on the surface. Independent on whether the hydrophobic sphere is positioned on top of a hydrophobic or hydrophilic area, repulsions are measured, with the same strength and decay length of the electrostatic interaction. Jump into contact distances and adhesion data, between a 20 m hydrophobic sphere and a heterogeneous surface that has equal hydrophobic and hydrophilic areas will average, whereas in all other cases the hydrophobic sphere will clearly differentiate between the different areas, accurately mapping high and low adhesion areas on the surface.U of I OnlyRestricted to the U of I community idenfinitely during batch ingest of legacy ETD
Transfection Mechanisms of Polyplexes, Lipoplexes, and Stealth Liposomes in α<sub>5</sub>β<sub>1</sub> Integrin Bearing DLD‑1 Colorectal Cancer Cells
Receptor
targeted, PEGylated transfection agents can improve stability
and delivery specificity of current cationic lipid and polymer based
nonviral gene delivery vehicles, but their mode of transfection is
poorly understood. We therefore investigated the transfection mechanisms
of 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP)/1,2-dioleoyl-<i>sn</i>-glycero-3-phosphoethanolamine (DOPE) lipoplexes, branched
polyethylenimine (bPEI) polyplexes, and bPEI encapsulated in either
PEGylated (stealth) nontargeted liposomes or PR_b peptide (targeted
to α<sub>5</sub>β<sub>1</sub> integrin) functionalized
stealth liposomes in DLD-1 colorectal cancer cells in vitro with gene
expression assays, flow cytometry and confocal microscopy. DOTAP/DOPE
and PR_b functionalized stealth liposomes mediated higher gene expression
compared to nontargeted stealth liposomes and bPEI. However DOTAP/DOPE
was internalized slowly leading to lower levels of DNA uptake. In
contrast, despite high internalization of bPEI polyplexes, gene expression
levels were low as DNA was unable to escape from the endosomes. Nontargeted
stealth liposomes also mediated low gene expression due to low amounts
of DNA internalized and slow internalization kinetics. PR_b functionalized
stealth liposomes struck an optimal balance among these transfection
agents with efficient transfection arising from fast integrin mediated
internalization kinetics, high amounts of DNA uptake, and endosomal
escape. We found α<sub>5</sub>β<sub>1</sub> integrin to
be a valuable target for gene delivery and that the caveolar endocytic
pathway may offer an advantage to receptor targeted PEGylated transfection
agents in DLD-1 cells
Increasing Cancer-Specific Gene Expression by Targeting Overexpressed α<sub>5</sub>β<sub>1</sub> Integrin and Upregulated Transcriptional Activity of NF-κB
We developed a modular multifunctional
nonviral gene delivery system
by targeting the overexpressed cancer surface receptor α<sub>5</sub>β<sub>1</sub> integrin and the upregulated transcriptional
activity of the cancer resistance mediating transcription factor NF-κB,
thereby introducing a new form of transcriptional targeting. NF-κB
regulated therapy can improve specificity of gene expression in cancer
tissue and also may offset NF-κB mediated cancer resistance.
We delivered a luciferase gene under the control of an NF-κB
responsive element (pNF-κB-Luc) encapsulated in a PR_b peptide
functionalized stealth liposome that specifically targets the α<sub>5</sub>β<sub>1</sub> integrin and achieved increased gene expression
in DLD-1 colorectal cancer cells compared to BJ-fibroblast healthy
cells <i>in vitro</i>. The multitargeted system was also
able to differentiate between cancer cells and healthy cells better
than either of the individually targeted systems. In addition, we
constructed a novel cancer therapeutic plasmid by cloning a highly
potent diphtheria toxin fragment A (DTA) expressing gene under the
control of an NF-κB responsive element (pNF-κB-DTA). A
dose-dependent reduction of cellular protein expression and increased
cytotoxicity in cancer cells was seen when transfected with PR_b functionalized
stealth liposomes encapsulating the condensed pNF-κB-DTA plasmid.
Our therapeutic delivery system specifically eradicated close to 70%
of a variety of cancer cells while minimally affecting healthy cells <i>in vitro</i>. Furthermore, the modular nature of the nonviral
design allows targeting novel pairs of extracellular receptors and
upregulated transcription factors for applications beyond cancer gene
therapy
Zeolite Growth by Addition of Subcolloidal Particles:Â Modeling and Experimental Validation
Bioresorbable Polymersomes for Targeted Delivery of Cisplatin
Nontoxic bioresorbable polymersomes
have been developed that efficiently
and site-selectively tether targeting peptides under mild conditions
with no toxic catalysts. The binding and release properties of these
polymersomes have been evaluated when targeting DLD-1 human colon
cancer cells overexpressing
the α<sub>5</sub>β<sub>1</sub> integrin. The delivery
efficacy to these cells is markedly improved over commonly used RGD
targeting peptides by use of an α<sub>5</sub>β<sub>1</sub>-specific targeting peptide, PR_b. Release profiles in buffered solution
from pH 7.4 to 4.5 were evaluated and compared to release after binding
to cells, and enzymatic degradation was identified as a major cause
of rapid payload release in the cell. Intracellular trafficking and
release were imaged <i>via</i> confocal microscopy in live
cells and colocalization with organelles was evaluated quantitatively
over time. Finally, the anticancer drug cisplatin was encapsulated
in the PR_b functionalized polymersomes and the presence of PR_b greatly
improved delivery efficacy, with increased cisplatin-induced losses
to targeted DLD-1 colon cancer cell viability. When delivered to CACO-2
model human epithelial cells expressing low levels of α<sub>5</sub>β<sub>1</sub> integrin, low toxicity was maintained,
suggesting that targeting was specific to α<sub>5</sub>β<sub>1</sub> overexpressing cells. These results demonstrate that PR_b-functionalized
bioresorbable polymersomes may be an attractive route to minimizing
the dose-limiting side effects associated with existing approaches
to cisplatin chemotherapy
Three-Dimensional Cell Entrapment as a Function of the Weight Percent of Peptide-Amphiphile Hydrogels
The design of scaffolds which mimic
the stiffness, nanofiber structure,
and biochemistry of the native extracellular matrix (ECM) has been
a major objective for the tissue engineering field. Furthermore, mimicking
the innate three-dimensional (3D) environment of the ECM has been
shown to significantly altered cellular response compared to that
of traditional two-dimensional (2D) culture. We report the development
of a self-assembling, fibronectin-mimetic, peptide-amphiphile nanofiber
scaffold for 3D cell culture. To form such a scaffold, 5 mol % of
a bioactive PR_g fibronectin-mimetic peptide-amphiphile was mixed
with 95 mol % of a diluent peptide-amphiphile (E2) whose purpose was
to neutralize electrostatic interactions, increase the gelation kinetics,
and promote cell survival. Atomic force microscopy verified the fibrilar
structure of the gels, and the mechanical properties were characterized
for various weight percent (wt %) formulations of the 5 mol % PR_g–95
mol % E2 peptide-amphiphile mixture. The 0.5 wt % formulations had
an elastic modulus of 429.0 ± 21.3 Pa whereas the 1.0 wt % peptide-amphiphile
hydrogels had an elastic modulus of 808.6 ± 38.1 Pa. The presence
of entrapped cells in the gels decreased the elastic modulus, and
the decrease was a function of cell loading. Although both formulations
supported cell proliferation, the 0.5 wt % gels supported significantly
greater NIH3T3/GFP fibroblast cell proliferation throughout the gels
than the 1.0 wt % gels. However, compared to the 0.5 wt % formulations,
the 1.0 wt % hydrogels promoted greater increases in mRNA expression
and the production of fibronectin and type IV collagen ECM proteins.
This study suggests that this fibronectin-mimetic scaffold holds great
promise in the advancement of 3D culture applications and cell therapies